MedPath

Role of autologous Platelet rich plasma in infertile females.

Not Applicable
Completed
Conditions
Health Condition 1: - Health Condition 2: N979- Female infertility, unspecified
Registration Number
CTRI/2021/05/033764
Lead Sponsor
vmmc and safdarjung hospital delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Infertile female between 21-37 years.

2. Persistent thin endometrial thickness <=6 mm on >=1 cycle in previous cycle even after conventional treatment with estradiol valearate.

3. HB >11 gm% and platelets >1.5 lakhs

Exclusion Criteria

1.History of symptoms of platelet dysfunction such as easy bruisability, frequent nose-bleeds, heavy menstrual bleeding, bleeding gums or excessive bleeding during dental procedures.

2.Blood borne disease like Hepatitis B, Hepatitis C, Syphilis, HIV.

3.NSAIDs intake in 10 days before the procedure

4.Pt on anticoagulant therapy

5.Severe Male factor for infertility

6.Tubal factor for infertility

7.WHO class 1 or 3 ovulatory dysfunction

8.Mullerian abnormality

9.Ashermann Syndrome

10.Moderate /severe endometriosis

11.Active vaginal/cervix infection/pelvic inflammatory disease.

12.Any significant co-morbidity/ psychiatric disorder which compromise or interfere with consent giving/study participation/ follow up or interpretation of study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary Outcome <br/ ><br>1)Change in endometrium thickness. <br/ ><br>2)change in endometrium vascularity <br/ ><br>Timepoint: 36-40 hours post PRP instillation
Secondary Outcome Measures
NameTimeMethod
Secondary outcome <br/ ><br>1)positive pregnancy rate <br/ ><br>2).clinical pregnancy rate <br/ ><br>Timepoint: <br/ ><br>1)positive pregnancy rate-14 DAYS after intrauterine insemination by urine pregnancy test. <br/ ><br>2)clinical pregnancy rate-28 days after intrauterine <br/ ><br>insemination by transvaginal ultrasound. <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath